Transjugular antegrade transvenous obliteration, with and without portal decompression, for management of rectal variceal hemorrhage.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Gabriel E Li, Jeffrey Forris Beecham Chick, Eric J Monroe, Matthew Abad-Santos, Ethan W Hua, David S Shin
{"title":"Transjugular antegrade transvenous obliteration, with and without portal decompression, for management of rectal variceal hemorrhage.","authors":"Gabriel E Li, Jeffrey Forris Beecham Chick, Eric J Monroe, Matthew Abad-Santos, Ethan W Hua, David S Shin","doi":"10.1186/s42155-024-00479-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report antegrade transvenous obliteration, with or without concurrent portosystemic shunt creation, for the treatment of hemorrhagic rectal varices.</p><p><strong>Materials and methods: </strong>Eight patients, including five (62.5%) females and three (37.5%) males, with mean age of 55.8 ± 13.8 years (range: 30-70 years), underwent transjugular-approach antegrade transvenous obliteration of rectal varices, with or without portosystemic shunt creation. Demographic data, procedural details, technical success of variceal obliteration, clinical success, adverse events, and follow-up outcomes were retrospectively recorded. Clinical success was defined as resolution of rectal hemorrhage.</p><p><strong>Results: </strong>Portal venous access was achieved via a transjugular intrahepatic approach in all patients. The inferior mesenteric vein was selected, and foamy sclerosant (1:2:3 mixture by volume of ethiodized oil: sodium tetradecyl sulfate: air) was injected into the rectal varices with antegrade balloon occlusion in seven (87.5%) and without balloon occlusion in one (12.5%). Five of eight (62.5%) patients underwent concomitant transjugular intrahepatic portosystemic shunt (TIPS) creation (mean diameter 8.4 ± 0.9-mm) immediately following transvenous obliteration. Technical success of variceal obliteration was achieved in all patients. There were no immediate post-procedural adverse events. There were no reported occurrences of rectal ischemia, perforation, or stricture following obliteration. Two (40%) of the patients who underwent concomitant TIPS creation developed hepatic encephalopathy within 30 days of the procedure, which was medically managed. Clinical resolution of hemorrhage was achieved in all patients with no recurrent rectal variceal hemorrhage during mean follow-up of 666 ± 396 days (range: 14 - 1,224 days).</p><p><strong>Conclusion: </strong>Transvenous obliteration, with or without concurrent TIPS creation, is feasible with promising results for the management of rectal variceal hemorrhage.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11371984/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CVIR Endovascular","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42155-024-00479-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To report antegrade transvenous obliteration, with or without concurrent portosystemic shunt creation, for the treatment of hemorrhagic rectal varices.

Materials and methods: Eight patients, including five (62.5%) females and three (37.5%) males, with mean age of 55.8 ± 13.8 years (range: 30-70 years), underwent transjugular-approach antegrade transvenous obliteration of rectal varices, with or without portosystemic shunt creation. Demographic data, procedural details, technical success of variceal obliteration, clinical success, adverse events, and follow-up outcomes were retrospectively recorded. Clinical success was defined as resolution of rectal hemorrhage.

Results: Portal venous access was achieved via a transjugular intrahepatic approach in all patients. The inferior mesenteric vein was selected, and foamy sclerosant (1:2:3 mixture by volume of ethiodized oil: sodium tetradecyl sulfate: air) was injected into the rectal varices with antegrade balloon occlusion in seven (87.5%) and without balloon occlusion in one (12.5%). Five of eight (62.5%) patients underwent concomitant transjugular intrahepatic portosystemic shunt (TIPS) creation (mean diameter 8.4 ± 0.9-mm) immediately following transvenous obliteration. Technical success of variceal obliteration was achieved in all patients. There were no immediate post-procedural adverse events. There were no reported occurrences of rectal ischemia, perforation, or stricture following obliteration. Two (40%) of the patients who underwent concomitant TIPS creation developed hepatic encephalopathy within 30 days of the procedure, which was medically managed. Clinical resolution of hemorrhage was achieved in all patients with no recurrent rectal variceal hemorrhage during mean follow-up of 666 ± 396 days (range: 14 - 1,224 days).

Conclusion: Transvenous obliteration, with or without concurrent TIPS creation, is feasible with promising results for the management of rectal variceal hemorrhage.

治疗直肠静脉曲张出血的经颈静脉前路经静脉阻塞术(带或不带门脉减压)。
目的:报告治疗出血性直肠静脉曲张的前路经静脉阻塞术,无论是否同时进行门静脉分流术:八名患者,包括五名(62.5%)女性和三名(37.5%)男性,平均年龄为 55.8 ± 13.8 岁(范围:30-70 岁),接受了经颈静脉入路前向经静脉直肠静脉曲张闭塞术,无论是否同时进行门静脉分流术。回顾性记录了人口统计学数据、手术细节、静脉曲张闭塞的技术成功率、临床成功率、不良事件和随访结果。临床成功定义为直肠出血缓解:所有患者均通过经颈静脉肝内途径进入门静脉。选择肠系膜下静脉,向直肠静脉曲张处注射泡沫硬化剂(按体积计算,乙碘油:十四烷基硫酸钠:空气的混合物为 1:2:3),其中 7 例(87.5%)进行了前向球囊闭塞,1 例(12.5%)未进行球囊闭塞。八名患者中有五名(62.5%)在经静脉阻塞后立即接受了经颈静脉肝内门体分流术(TIPS)(平均直径为 8.4 ± 0.9 毫米)。所有患者的静脉曲张阻塞均取得了技术成功。术后未立即发生不良事件。闭塞术后没有发生直肠缺血、穿孔或狭窄的报道。有两名(40%)同时接受 TIPS 手术的患者在术后 30 天内出现肝性脑病,经药物治疗后得到控制。在平均 666 ± 396 天(范围:14 - 1,224 天)的随访期间,所有患者的出血均得到临床缓解,直肠静脉曲张出血未再复发:结论:在治疗直肠静脉曲张出血方面,经静脉阻塞术(无论是否同时进行 TIPS 创建)是可行的,且效果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CVIR Endovascular
CVIR Endovascular Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
2.30
自引率
0.00%
发文量
59
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信